In detail, growing evidence supports the idea that cholesterol metabolism and cholesterol oxidation products contribute to beta-amyloid plaque formation, tau hyperphosphorylation, and that cholesterol oxidation products concur to AD neurodegeneration and pathogenesis [80,89], although this process is not entirely clear. Here, MAPT is linked to Alzheimer disease.